In some cases, KLF12 was overexpressed and served as a tumor suppressor, for example, in bladder cancer (Tang et al., 2021) and lung cancer (Godin-Heymann et al., 2016). This evidence concerns the gene KLF12 and urinary bladder carcinoma.